| Code | 3489A | ||||||||||
| MA number | 16/0541/12-S | ||||||||||
| Product Form: | tbl ent 30x100 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 14.12.2012 |
| PIL: |
PIL_Stadapyrin 04.2020.doc
|
| SPC: |
SPC_Stadapyrin 04.2020.doc
|
| Safety feature | Yes |
| Data update: | 23.03.2018 |
